A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.
about
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian PerspectivePatient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.Systemic methotrexate therapy for psoriasis: past, present and future.Efficacy, Safety, and Out-of-pocket Costs are the Most Important Factors to Patients in Choosing a Psoriasis Therapy.The cost of biologics for psoriasis is increasingOral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.Non-alcoholic fatty liver disease and psoriasis: So far, so near.Health economic analyses of psoriasis management: a systematic literature search.Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.A Preliminary, Open Label, Single-arm Study of Calcipotriene/Betamethasone Topical Suspension as a Supplement to Non-biologic Systemic Therapy for Psoriasis.The costs of psoriasis medications.Apremilast as a treatment for psoriasis.Cost effectiveness of biologic therapies for plaque psoriasis.Phototherapy, psoriasis, and the age of biologics.Treating moderate to severe psoriasis - best use of biologics.Systemic therapies for psoriasis: an evidence-based update.Psoriasis treatment and management - a systematic review of full economic evaluations.Systematic review of cost-effectiveness analyses of treatments for psoriasis.Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis.Biosimilars for psoriasis: clinical studies to determine similarity.[Phototherapy in the era of biologicals].Phototherapy in France: quantitative data from the National Health Insurance register.Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis.Phototherapy trends in dermatology.Biologicals and small molecules in psoriasis: A systematic review of economic evaluations.Phototherapy in France: quantitative data (2007-2016) from the National Health Insurance Register.Healthcare resource utilization, healthcare costs and dose escalation in psoriasis patients initiated on ustekinumab versus adalimumab: a retrospective claim study.Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting.Economic Burden Can Be the Major Determining Factor Resulting in Short-Term Intermittent and Repetitive Ustekinumab Treatment for Moderate-to-Severe Psoriasis.
P2860
Q26747639-2783B02F-C766-4D19-8530-37F98F4C34ADQ33800651-CB0683A4-1D99-482B-B404-BCA669F65BDCQ34356265-DAB206C3-C6B7-4121-98F0-7C8EF5A4D4CEQ34846987-A6C5525F-5F20-4D81-81BD-0F2690BFC7A3Q34973745-AC8E3AD2-36E3-4BAE-B125-D44135B1D094Q34996214-B4A9B502-B984-4D73-9A13-65ABFC434AA1Q35237307-E703DA3D-08E1-4E86-99D2-5D965E441749Q36082201-77D1A38A-4C30-42F8-8547-C9C76B9A393DQ36368478-EB028F91-B414-44E8-9A34-8E5F5D433825Q36982667-214F9F96-FF98-4C4F-BA60-1640C2DA004BQ37468355-3B5157F6-788D-46C9-961D-4F033D20D9EAQ38019980-DEE515DB-143A-4C53-BC5A-6CACC1E9E267Q38108567-433375F6-32A2-4AC8-A7E4-2FD844AC7BBBQ38169210-1AE7D04E-DF24-479D-8450-80217364516FQ38174153-676FCF77-4AE5-4610-9EB4-7B82629F5B56Q38185297-A7D8F117-F137-42FE-BD49-115FB9C44949Q38260967-CA45056B-5095-4EDD-87D4-190AFEBA595DQ38283299-D41D45C2-B4E0-4C0F-8999-7FF9B3584DBCQ38673099-39C215FF-8C32-4C22-BC7E-8F538227AD5AQ38957406-876FF9BC-1664-4690-A668-0C82BBA2B62BQ43872006-A08AA42D-5444-4940-9F5B-2882C98A43F7Q43916014-38019E98-401B-440E-8F93-34F7D5DD5E84Q45176250-EFD04F74-B866-4712-89C3-1EC4B8616FADQ45960097-E40192D3-EE21-410C-BDE1-0CA823D09E8DQ47292115-977B4AA3-7977-4D07-B493-C8331B83FB85Q47336363-50B78B29-DA80-4E46-BD03-336CC051157CQ51362052-33DA3A4A-D838-49BE-8800-028D5C3E11D3Q52855161-B261ECDF-7D6B-4F95-AA91-9DD55921F0A5Q55193949-6A2C45EA-77F7-47FE-BBBD-B27E3EA2BE7C
P2860
A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A pharmacoeconomic analysis of ...... t choices and cost efficiency.
@en
A pharmacoeconomic analysis of ...... t choices and cost efficiency.
@nl
type
label
A pharmacoeconomic analysis of ...... t choices and cost efficiency.
@en
A pharmacoeconomic analysis of ...... t choices and cost efficiency.
@nl
prefLabel
A pharmacoeconomic analysis of ...... t choices and cost efficiency.
@en
A pharmacoeconomic analysis of ...... t choices and cost efficiency.
@nl
P2860
P1476
A pharmacoeconomic analysis of ...... nt choices and cost efficiency
@en
P2093
Jonathan P Staidle
Tushar S Dabade
P2860
P304
P356
10.1517/14656566.2011.590475
P407
P577
2011-07-08T00:00:00Z